Mosquito-borne viral diseases remain a significant public health concern in tropical and subtropical regions. Among them, dengue and chikungunya are two rapidly expanding threats that share similar transmission routes, clinical manifestations, and geographical distribution. As global travel and climate change continue to expand mosquito habitats, outbreaks of these viruses are becoming more frequent and complex.

Recent epidemiological data indicate that dengue and chikungunya are intensifying in different regions simultaneously, increasing the burden on healthcare systems and public health surveillance.

In the Western Pacific Region, dengue cases in countries such as Cambodia and Laos increased by more than 60% in early 2026 compared with 2025, with DENV-2 currently dominant in Singapore.

In the Americas, the Pan American Health Organization (PAHO) has reported a sustained rise in chikungunya cases, including the re-emergence of local transmission in areas that had not reported the virus for several years.

These evolving trends highlight the urgent need for robust diagnostic capacity and coordinated surveillance systems. Accurate and timely diagnostic tools play a critical role in disease surveillance, clinical management, and outbreak control.

Understanding the Viruses: Dengue and Chikungunya

Although dengue and chikungunya are transmitted by the same mosquito species, they are caused by different viruses and can lead to distinct clinical complications.

-Dengue: The “Breakbone Fever”

Cause & Spread: Dengue virus (4 serotypes), via Aedes aegypti & Aedes albopictus mosquitoes.
Symptoms: High fever (>39°C), headache, joint/muscle pain, skin flushing, and rash. Severe dengue may cause hemorrhage or shock.
Treatment: Supportive only. Hydration and paracetamol advised. Avoid NSAIDs due to bleeding risk.

-Chikungunya: The “Stooping” Virus

Cause & Spread: Transmitted by Aedes mosquitoes.
Symptoms: High fever, crippling joint pain, rash, and long-term arthritis.
Treatment: Symptomatic; avoid NSAIDs if dengue co-infection is possible.

Why Timely Diagnosis Saves Lives

Because dengue and chikungunya can present with similar early clinical symptoms, accurate laboratory testing is essential for guiding patient management and public health response. Timely diagnosis helps:

1. Prevent Severe Outcomes
- Early treatment of malaria reduces neurological damage.
- Fluid management in dengue prevents circulatory collapse.
2. Guide Clinical Decisions
- Knowing if it’s chikungunya or dengue avoids risky medication choices.

Treatment focuses on symptom relief and supportive care. If dengue infection cannot be ruled out, NSAIDs should be avoided until dengue has been excluded.

Diagnostic Challenges in Co-Endemic Regions

In many tropical regions, dengue and chikungunya circulate simultaneously, creating significant diagnostic challenges.

Both diseases are transmitted by the same mosquito vectors, share similar early symptoms, including fever, rash, and joint pain, and may occur as co-infections

Therefore, rapid, sensitive, and specific laboratory diagnostics are essential for:accurate differential diagnosis, effective outbreak monitoring, timely public health response

Macro & Micro-Test Integrated Solutions for Mosquito-Borne Viruses

To support the full spectrum of dengue and chikungunya control strategies, Macro & Micro-Test provides an integrated diagnostic portfolio covering rapid screening, molecular confirmation, and genomic surveillance.

These solutions enable healthcare institutions and laboratories to respond effectively across different stages of outbreak management, from frontline screening to advanced epidemiological research.

Scenario 1: Rapid Screening and Targeted Surveillance

Application: Fever clinics and primary healthcare facilities, Community screening in outbreak regions, Port health and border quarantine stations.

Dengue NS1 Antigen:Enables early detection within 1–3 days after symptom onset, with results available in 15 minutes.

Dengue Virus IgM/IgG Antibody: Supports determination of primary versus secondary infection.

Dengue NS1 Antigen + IgM/IgG Dual: Simultaneous antigen and antibody detection, covering both early and later stages of infection.

Chikungunya Virus IgM/IgG Antibody: Enables rapid assessment of recent infection or prior exposure.

Scenario 2: Precision Diagnosis and Emergency Response

Application : Hospital clinical laboratories, National and regional CDC laboratories, Mobile laboratories for outbreak response.

Dengue Virus I/II/III/IV Nucleic Acid: Detects and differentiates four dengue serotypes low to 500 copies/mL.

Lyophilized Dengue Virus PCR Kit: Enables room-temperature transportation and rapid deployment.

Dengue / Zika / Chikungunya Multiplex: Simultaneous detection of three major arboviruses,enablingefficient differential diagnosis during complex outbreaks.

Chikungunya Virus PCR Detection Kit: Suitable for early infection and low viral load cases with LoD of 200 copies/mL.

Compatible with the AIO 800 Fully Automated Sample-to-Answer System, minimizing manual operation and contamination risk

Scenario 3: Genomic Surveillance and Viral Lineage Analysis

Application: National reference laboratories, Public health research institutions, Academic and epidemiological research centers

-Supports virus origin tracing and outbreak investigation

-Enables mutation monitoring and evolutionary analysis

-Flexible workflows for both manual and automated sequencing pipelines, enabling increased throughput and reproducibility.

Comprehensive Diagnostics for Arbovirus Control

Macro & Micro-Test provides a complete diagnostic solution for mosquito-borne virus detection, supporting every stage of outbreak management:

✔ Rapid screening for frontline healthcare settings
✔ Molecular confirmation for accurate diagnosis
✔ Whole-genome analysis for epidemiological surveillance

With high-performance assays, flexible workflows, and automation-ready platforms, these solutions empower laboratories and public health systems to strengthen preparedness and response to emerging arboviral threats worldwide.

Post time: Mar-11-2026